Arthur Bedrosian, Petitioner v. United States, et al.
Case Number:
22-598
Court:
Nature of Suit:
Firms
-
June 20, 2023
Justices Won't Review Drug Exec's $1.4M Tax Penalty
A former pharmaceutical executive lost his last chance to reduce a $1.4 million penalty for failing to report a foreign bank account when the U.S. Supreme Court declined on Tuesday to hear the case.
-
May 16, 2023
US Urges Justices Not To Review Drug Exec's $1M Tax Penalty
The U.S. Supreme Court should not accept a drug company executive's challenge to lower courts' findings that there is an objective standard for his reckless failure to report foreign bank accounts, triggering a 50% penalty on the deposits that amounted to $1.4 million, the federal government said.
-
January 03, 2023
Ex-Pharma CEO Asks Justices To Review $1M In Tax Penalties
A former pharmaceutical CEO asked the U.S. Supreme Court to review a Third Circuit decision upholding $1 million in Internal Revenue Service penalties against him for failing to report a Swiss bank account, saying the circuit wrongly considered his actions reckless.